Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ted Jack Kaptchuk, B.A.

Title
Institution
Department
Address
Phone
Fax
Other Positions
Title
Institution
Department

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R33AT009306 (NAPADOW, VITALY) Sep 15, 2016 - May 31, 2022
    NIH
    Optimization of brain-based mechanisms supporting psychosocial aspects of acupuncture therapy - a hyperscanning fMRI study
    Role: Co-Principal Investigator
  2. R61AT009306 (NAPADOW, VITALY) Sep 15, 2016 - Sep 14, 2018
    NIH
    Optimization of brain-based mechanisms supporting psychosocial aspects of acupuncture therapy - a hyperscanning fMRI study
    Role: Principal Investigator
  3. R01AT008573 (LEMBO, ANTHONY J) Sep 1, 2015 - Jun 30, 2021
    NIH
    Efficacy of Open-Label Placebo, Double-Blind Placebo, and Peppermint Oil in IBS
    Role: Principal Investigator
  4. R01AT005280 (GOLLUB, RANDY LYANNE) Feb 1, 2010 - Jan 31, 2016
    NIH
    An fMRI study of expectancy on acupuncture treatment outcomes in knee OA
    Role: Co-Principal Investigator
  5. R01AT004662 (KOKKOTOU, EFI G.) May 1, 2009 - Apr 30, 2016
    NIH
    Omics and Variable Responses to Placebo and Acupuncture in Irritable Bowel Syndro
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Pan Y, Frank ML, Kaptchuk TJ, Nestoriuc Y. "Let's see what happens:"-Women's experiences of open-label placebo treatment for menopausal hot flushes in a randomized controlled trial. PLoS One. 2022; 17(11):e0276499. PMID: 36331921; PMCID: PMC9635716.
    Citations:    Fields:    Translation:Humans
  2. Schlaeger JM, Suarez ML, Glayzer JE, Kobak WH, Meinel M, Steffen AD, Burke LA, Pauls HA, Yao Y, Takayama M, Yajima H, Kaptchuk TJ, Takakura N, Foster D, Wilkie DJ. Protocol for double-blind RCT of acupuncture for vulvodynia. Contemp Clin Trials Commun. 2022 Dec; 30:101029. PMID: 36387991; PMCID: PMC9649367.
    Citations:    
  3. Desloge AA, Patil CL, Glayzer JE, Suarez ML, Kobak WH, Meinel M, Steffen AD, Burke LA, Yao Y, Takayama M, Yajima H, Kaptchuk TJ, Takakura N, Foster DC, Wilkie DJ, Schlaeger JM. Women's Experience of Living with Vulvodynia Pain: Why They Participated in a Randomized Controlled Trial of Acupuncture. J Integr Complement Med. 2022 Sep 21. PMID: 36130137.
    Citations:    
  4. Muench A, Giller J, Morales KH, Culnan E, Khader W, Kaptchuk TJ, McCall WV, Perlis ML. Do Placebos Primarily Affect Subjective as Opposed to Objective Measures? A Meta-Analysis of Placebo Responses in Insomnia RCTs. Behav Sleep Med. 2022 Sep 12; 1-13. PMID: 36094215.
    Citations:    Fields:    
  5. Hruschak V, Flowers KM, Patton M, Merchantz V, Schwartz E, Edwards R, Kaptchuk T, Kang J, Dossett M, Schreiber K. Experiences of Patients Taking Conditioned Open-Label Placebos for Reduction of Postoperative Pain and Opioid Exposure After Spine Surgery. Int J Behav Med. 2022 Aug 01. PMID: 35915346.
    Citations:    Fields:    
  6. Ongaro G, Ballou S, Kube T, Haas J, Kaptchuk TJ. Doctors Speak: A Qualitative Study of Physicians' Prescribing of Antidepressants in Functional Bowel Disorders. Cult Med Psychiatry. 2022 Jun 28. PMID: 35764862.
    Citations:    Fields:    
  7. Ballou S, Iturrino J, Rangan V, Cheng V, Kelley JM, Lembo A, Kaptchuk TJ, Nee J. Improving Medication Tolerance: A Pilot Study in Disorders of Gut-brain Interaction Treated With Tricyclic Antidepressants. J Clin Gastroenterol. 2022 May-Jun 01; 56(5):452-456. PMID: 34091518.
    Citations: 3     Fields:    Translation:Humans
  8. Yang E, Lu W, Muñoz-Vergara D, Goldfinger E, Kaptchuk TJ, Napadow V, Ahn AC, Wayne PM. Skin Temperature of Acupoints in Health and Disease: A Systematic Review. J Integr Complement Med. 2022 Jul; 28(7):552-568. PMID: 35475679.
    Citations:    Translation:Humans
  9. Ballou S, Haas JW, Iturrino J, Nee J, Kirsch I, Rangan V, Cheng V, Lembo A, Kaptchuk TJ, Kelley JM. Psychological Predictors of Response to Open-Label Versus Double-Blind Placebo in a Randomized Controlled Trial in Irritable Bowel Syndrome. Psychosom Med. 2022 Jul-Aug 01; 84(6):738-746. PMID: 35412513; PMCID: PMC9271597.
    Citations:    Fields:    Translation:Humans
  10. Nurko S, Saps M, Kossowsky J, Zion SR, Di Lorenzo C, Vaz K, Hawthorne K, Wu R, Ciciora S, Rosen JM, Kaptchuk TJ, Kelley JM. Effect of Open-label Placebo on Children and Adolescents With Functional Abdominal Pain or Irritable Bowel Syndrome: A Randomized Clinical Trial. JAMA Pediatr. 2022 04 01; 176(4):349-356. PMID: 35099543; PMCID: PMC8804974.
    Citations: 1     Fields:    Translation:Humans
  11. Ongaro G, Kaptchuk TJ. Reply to Arandia and Di Paolo. Pain. 2022 04 01; 163(4):e605-e606. PMID: 35302977.
    Citations:    Fields:    
  12. Ballou S, Hassan R, Nee J, Iturrino J, Rangan V, Cheng V, Conboy L, Kirsch I, Lembo A, Kaptchuk TJ, Kelley J. Are They Side Effects? Extraintestinal Symptoms Reported During Clinical Trials of Irritable Bowel Syndrome May Be More Severe at Baseline. Clin Gastroenterol Hepatol. 2022 Dec; 20(12):2888-2894.e1. PMID: 35339669; PMCID: PMC9500110.
    Citations:    Fields:    
  13. Vollert J, Wang R, Regis S, Yetman H, Lembo AJ, Kaptchuk TJ, Cheng V, Nee J, Iturrino J, Loscalzo J, Hall KT, Silvester JA. Genotypes of Pain and Analgesia in a Randomized Trial of Irritable Bowel Syndrome. Front Psychiatry. 2022; 13:842030. PMID: 35401282; PMCID: PMC8983929.
    Citations: 1     
  14. Haas JW, Ongaro G, Jacobson E, Conboy LA, Nee J, Iturrino J, Rangan V, Lembo A, Kaptchuk TJ, Ballou S. Patients' experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study. BMC Psychol. 2022 Feb 04; 10(1):20. PMID: 35120572; PMCID: PMC8815135.
    Citations: 1     Fields: